FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened

Apr.17.2025
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA staff cuts impact tobacco enforcement: HHS layoffs jeopardize fines on retailers, potentially hindering tobacco law enforcement.

Key points:

FDA Layoffs Affect Tobacco Enforcement: The US Department of Health and Human Services (HHS) laid off approximately 10,000 employees on April 1, including the department responsible for fining retailers for violations under the FDA. This move may result in a slowdown in tobacco enforcement efforts.

FDA has requested that some laid-off employees temporarily return to work to help with unfinished cases. About 20 employees have agreed to return until their official departure on June 2nd.

 

Weakened regulatory ability: Layoffs have weakened the FDA's ability to enforce penalties on non-compliant retailers, experts worry this may undermine the recent decline in tobacco use rates.

Fines Income Affected: The disbandment of the Civil Fines Office could impact FDA's fines income, leading to a reduction in federal revenue. This office is also a key tool in cracking down on the illegal distribution of e-cigarettes.

Reasons for HHS Staff Reduction: The Department of Health and Human Services stated that the layoffs are primarily focused on administrative and redundant positions. However, FDA officials believe that this move severely undermines tobacco enforcement capabilities and could lead to looser retailer behavior.


According to a report from POLITICO on April 14th, the U.S. Food and Drug Administration (FDA) has recently asked some tobacco enforcement agents who were previously laid off to temporarily return to work in order to address the halt in regulatory capacity caused by significant manpower reductions.

 

According to four federal health officials, the layoffs were carried out by the Secretary of the Department of Health and Human Services (HHS), Robert F. Kennedy Jr., on April 1st, resulting in the dismissal of around 10,000 employees, including those responsible for imposing civil fines on non-compliant retailers at the FDA. This department was previously able to handle over a hundred cases of illegal sales per week, focusing on punishing stores that sell cigarettes and e-cigarettes to minors.

 

Informed officials have stated that the recent layoffs have crippled the FDA's main enforcement tool against tobacco retailers, leading to a halt in related case processing. In order to maintain enforcement continuity as much as possible, senior FDA officials recently invited some laid-off employees to return on a short-term basis to assist with processing before their formal departure date on June 2nd. As of last Friday, more than 20 people have agreed to return to work. It is reported that some employees are concerned that if they refuse to return, they may lose their severance package.

 

Kennedy's cost-cutting measures have not affected the team responsible for handling warning letters and comprehensive bans, but there is a lack of a team responsible for enforcing fines and sales bans. Former FDA Center for Tobacco Products Director Mitch Zeller stated that this move essentially allows retailers to "flout the law," severely undermining policies aimed at controlling youth tobacco use.

 

In 2024, the tobacco use rate among American teenagers hit a new low in 25 years, causing concern among health experts. They worry that without continued federal enforcement support, this achievement could face the risk of reversal. At the same time, the Civil Monetary Penalty Office is also a key tool in combating the illegal distribution of e-cigarettes.

 

Currently, it is not clear why the Department of Health and Human Services (HHS) is focusing on dismantling the office responsible for civil penalties, which is a part of the U.S. Food and Drug Administration's (FDA) tobacco enforcement system known as the Division of Business Operations. The entire operational costs of the FDA Center for Tobacco Products are covered by user fees paid by the industry, with no involvement of federal budgets. This means that layoffs will not result in any savings for taxpayers, but could potentially reduce the Treasury's revenue from fines imposed by the FDA.

 

After layoffs, the FDA has not yet announced its future plan for enforcement restructuring. According to internal sources, some senior officials at the FDA's Center for Tobacco Products are still trying to fully restore its functions, but some employees have been told that returning to work in the short term does not necessarily mean they will be rehired in the future.

 

Department of Health and Human Services spokesperson Andrew Nixon stated in a declaration that laid-off employees may be required to work for a short period before their official departure date (June 2nd), with the aim of "minimizing disruptions to agency functions and ensuring a smooth transition.

 

Kennedy stated in a previous interview with the media that all positions that were cut were either administrative or considered redundant. He emphasized that the relevant work would be taken over by other programs through integration. Internal officials at the FDA have stated that these cuts have effectively paralyzed their tobacco enforcement actions. The agency's enforcement process consists of three stages: first-time offenders receive a warning letter, repeated violations result in civil penalties, and the most serious violations lead to a ban on all tobacco sales.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
British American Tobacco Japan (BAT Japan) has introduced virto Bright Peach Click, a new heated tobacco stick designed for the glo Hilo system. The product expands the existing virto consumable lineup with a combination of tobacco, menthol and ripe peach flavors, featuring a capsule mechanism that releases additional fruit flavor when activated. The product launched in Japan on July 27, 2026, through glo official online channels, convenience stores and tobacco retailers.
Aug.03
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
Product | KT&G Brings LOOP Nicotine Pouches to South Africa, Supporting ASF’s Expansion Across Africa
KT&G has introduced nicotine pouch brand LOOP in South Africa, expanding its modern oral nicotine portfolio. Developed by Swedish company Another Snus Factory (ASF), LOOP is a tobacco-free nicotine pouch brand. KT&G and U.S. tobacco company Altria previously participated in ASF’s strategic development, and the South Africa launch represents a further step in LOOP’s international expansion.
Aug.06
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05